Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Pelzel, Heather R ^a,b   Schlamp, Cassandra L ^b   Nickells, Robert W ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; HISTONE H4; TRICHOSTATIN A; HISTONE; HISTONE DEACETYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CHROMATIN; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE SILENCING; MOUSE; NERVE CELL NECROSIS; NONHUMAN; OPTIC NERVE INJURY; PROMOTER REGION; PROTEIN TRANSPORT; RETINA GANGLION CELL; TRANSCRIPTION REGULATION; ACETYLATION; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETYLATION; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; HISTONE DEACETYLASES; HISTONES; MICE; OPTIC NERVE INJURIES; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77952656234     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-62     Document Type: Article

References (62)

1. Chang LK, Putcha GV, Deshmukh M, Johnson EM. Mitochondrial involvement in the point of no return in neuronal apoptosis. Biochimie 2002, 84(2-3):223-231. 10.1016/S0300-9084(02)01372-X, 12022953.
2. Cha JH. Transcriptional dysregulation in Huntington's disease. Trends Neurosci 2000, 23(9):387-392. 10.1016/S0166-2236(00)01609-X, 10941183.
3. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci 2004, 45(4):1247-1258. 10.1167/iovs.03-1123, 15037594.
4. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson ED, Steele MR, Inman DM, Vetter ML, Horner PJ, Marsh-Armstrong N. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 2008, 28(2):548-561. 10.1523/JNEUROSCI.3714-07.2008, 18184797.
5. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, Zack DJ. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci 2007, 48(12):5539-5548. 10.1167/iovs.07-0542, 18055803.
6. Sugars KL, Rubinsztein DC. Transcriptional abnormalities in Huntington disease. Trends Genet 2003, 19(5):233-238. 10.1016/S0168-9525(03)00074-X, 12711212.
7. Duke DC, Moran LB, Pearce RK, Graeber MB. The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 2007, 8(2):83-94. 10.1007/s10048-006-0077-6, 17211632.
8. Ferraiuolo L, Heath PR, Holden H, Kasher P, Kirby J, Shaw PJ. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci 2007, 27(34):9201-9219. 10.1523/JNEUROSCI.1470-07.2007, 17715356.
9. Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 2008, 31(1):89-101. 10.1016/j.nbd.2008.03.011, 18502140.
10. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004, 101(7):2173-2178. 10.1073/pnas.0308512100, 357071, 14769913.
11. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW. Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis 2001, 7:192-201.
12. Schlamp CL, Thliveris AT, Li Y, Kohl LP, Knop C, Dietz JA, Larsen IV, Imesch P, Pinto LH, Nickells RW. Insertion of the beta Geo promoter trap into the Fem1c gene of ROSA3 mice. Mol Cell Biol 2004, 24(9):3794-3803. 10.1128/MCB.24.9.3794-3803.2004, 387761, 15082774.
13. Chidlow G, Casson R, Sobrado-Calvo P, Vidal-Sanz M, Osborne NN. Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study. Mol Vis 2005, 11:387-396.
14. Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW. Identification of the bcl-2 family of genes in the rat retina. Invest Ophthalmol Vis Sci 1997, 38(12):2545-2553.
15. Weishaupt JH, Klocker N, Bahr M. Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells. J Mol Neurosci 2005, 26(1):17-25. 10.1385/JMN:26:1:017, 15968082.
16. Ivanov D, Dvoriantchikova G, Nathanson L, McKinnon SJ, Shestopalov VI. Microarray analysis of gene expression in adult retinal ganglion cells. FEBS Lett 2006, 580(1):331-335. 10.1016/j.febslet.2005.12.017, 16376886.
17. Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002, 22(10):3977-3986.
18. Napankangas U, Lindqvist N, Lindholm D, Hallbook F. Rat retinal ganglion cells upregulate the pro-apoptotic BH3-only protein Bim after optic nerve transection. Brain Res Mol Brain Res 2003, 120(1):30-37. 10.1016/j.molbrainres.2003.09.016, 14667574.
19. Park KH, Cozier F, Ong OC, Caprioli J. Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci 2001, 42(7):1522-1530.
20. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002, 43(4):1077-1087.
21. Huang W, Fileta J, Guo Y, Grosskreutz CL. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr Eye Res 2006, 31(3):265-271. 10.1080/02713680500545671, 16531284.
22. Jenuwein T, Allis CD. Translating the histone code. Science 2001, 293(5532):1074-1080. 10.1126/science.1063127, 11498575.
23. de la Cruz X, Lois S, Sanchez-Molina S, Martinez-Balbas MA. Do protein motifs read the histone code?. Bioessays 2005, 27(2):164-175. 10.1002/bies.20176, 15666348.
24. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 2007, 76:75-100. 10.1146/annurev.biochem.76.052705.162114, 17362198.
25. Bottomley MJ. Structures of protein domains that create or recognize histone modifications. EMBO Rep 2004, 5(5):464-469. 10.1038/sj.embor.7400146, 1299057, 15184976.
26. Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, Sambucini S, Bottomley MJ, Lo Surdo P, Carfi A, Koch U, De Francesco R, Steinkuhler C, Gallinari P. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci USA 2007, 104(44):17335-17340. 10.1073/pnas.0706487104, 2077257, 17956988.
27. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370(Pt 3):737-749. 10.1042/BJ20021321, 1223209, 12429021.
28. Longworth MS, Laimins LA. Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src. Oncogene 2006, 25(32):4495-4500. 10.1038/sj.onc.1209473, 16532030.
29. Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004, 93(1):57-67. 10.1002/jcb.20179, 15352162.
30. Li Y, Schlamp CL, Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci 1999, 40(5):1004-1008.
31. Andreau K, Castedo M, Perfettini JL, Roumier T, Pichart E, Souquere S, Vivet S, Larochette N, Kroemer G. Preapoptotic chromatin condensation upstream of the mitochondrial checkpoint. J Biol Chem 2004, 279(53):55937-55945. 10.1074/jbc.M406411200, 15498771.
32. Drager UC, Olsen JF. Ganglion cell distribution in the retina of the mouse. Invest Ophthalmol Vis Sci 1981, 20(3):285-293.
33. Li Y, Semaan SJ, Schlamp CL, Nickells RW. Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci 2007, 8:19. 10.1186/1471-2202-8-19, 1831479, 17338819.
34. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995, 36(5):774-786.
35. Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, John SW. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 2005, 1(1):17-26. 10.1371/journal.pgen.0010004, 1183523, 16103918.
36. Li Y, Kao GD, Garcia BA, Shabanowitz J, Hunt DF, Qin J, Phelan C, Lazar MA. A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev 2006, 20(18):2566-2579. 10.1101/gad.1455006, 1578679, 16980585.
37. Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. Embo J 2003, 22(24):6537-6549. 10.1093/emboj/cdg615, 291810, 14657026.
38. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001, 413(6857):739-743. 10.1038/35099568, 11607033.
39. Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007, 8(4):307-318. 10.1038/nrm2143, 17342184.
40. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland DG, Zhang Y, Kaelin WG. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007, 128(5):889-900. 10.1016/j.cell.2007.02.013, 17320163.
41. Karagianni P, Wong J. HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 2007, 26(37):5439-5449. 10.1038/sj.onc.1210612, 17694085.
42. Boutillier AL, Trinh E, Loeffler JP. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J Neurochem 2003, 84(4):814-828. 10.1046/j.1471-4159.2003.01581.x, 12562525.
43. Karagiannis TC, El-Osta A. Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer. Epigenetics 2006, 1(3):121-126.
44. Jiang H, Nucifora FC, Ross CA, DeFranco DB. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum Mol Genet 2003, 12(1):1-12. 10.1093/hmg/ddg002, 12490527.
45. Jin K, Mao XO, Simon RP, Greenberg DA. Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. J Mol Neurosci 2001, 16(1):49-56. 10.1385/JMN:16:1:49, 11345520.
46. McCampbell A, Taye AA, Whitty L, Penney E, Steffan JS, Fischbeck KH. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci USA 2001, 98(26):15179-15184. 10.1073/pnas.261400698, 65003, 11742087.
47. Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM, Marsh JL. Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum Mol Genet 2008, 17(23):3767-3775. 10.1093/hmg/ddn273, 2581431, 18762557.
48. Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PA, Steffah JS, Marsh JL, Thompson LM, Lewis CM, Marks PA, Bates GP. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 2003, 100(4):2041-2046. 10.1073/pnas.0437870100, 149955, 12576549.
49. Saha RN, Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006, 13(4):539-550. 10.1038/sj.cdd.4401769, 1963416, 16167067.
50. Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, Ratan RR. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci USA 2003, 100(7):4281-4286. 10.1073/pnas.0737363100, 153084, 12640146.
51. Chen B, Cepko CL. HDAC4 regulates neuronal survival in normal and diseased retina. Science 2009, 323(5911):256-259. 10.1126/science.1166226, 19131628.
52. Seo HW, Kim EJ, Na H, Lee MO. Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1. FEBS Lett 2009, 583(1):55-60. 10.1016/j.febslet.2008.11.044, 19071119.
53. Weber AJ, Harman CD. BDNF preserves the dendritic morphology of alpha and beta ganglion cells in the cat retina after optic nerve injury. Invest Ophthalmol Vis Sci 2008, 49(6):2456-2463. 10.1167/iovs.07-1325, 18263808.
54. Li Y, Schlamp CL, Poulsen KP, Nickells RW. Bax-dependent and independent pathways of retinal ganglion cell death induced by different damaging stimuli. Exp Eye Res 2000, 71(2):209-213. 10.1006/exer.2000.0873, 10930325.
55. Bortner CD, Sifre MI, Cidlowski JA. Cationic gradient reversal and cytoskeleton-independent volume regulatory pathways define an early stage of apoptosis. J Biol Chem 2008, 283:7219-7229. 10.1074/jbc.M707809200, 2680553, 18187415.
56. Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, Rosenberg PA, Levitan ES, Aizenman E. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci USA 2007, 104(3568):3573.
57. Koeberle PD, Wang Y, Schlichter LC. Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ 2010, 17:134-44. 10.1038/cdd.2009.113, 19696788.
58. Azarian SM, Schlamp CL, Williams DS. Characterization of calpain II in the retina and photoreceptor outer segments. J Cell Sci 1993, 105(Pt 3):787-798.
59. Pelzel HR, Schlamp CL, Poulsen GL, Ver Hoeve JA, Nork TM, Nickells RW. Decrease of cone opsin mRNA in experimental ocular hypertension. Mol Vis 2006, 12(1272):1282.
60. Schlamp CL, Nickells RW. Light and dark cause a shift in the spatial expression of a neuropeptide-processing enzyme in the rat retina. J Neurosci 1996, 16(7):2164-2171.
61. Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?. Drug Discov Today 2005, 10(3):197-204. 10.1016/S1359-6446(04)03309-4, 15708534.
62. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 2008, 409(2):581-589. 10.1042/BJ20070779, 17868033.